The Chinese company Huawei has achieved a new achievement by surpassing its competitors “Apple” and “Samsung” by introducing a long-awaited feature in smart watches, which is assessing the possibility of developing diabetes.
However, this feature does not replace well-known traditional methods, such as finger pricks or usual glucose meters.
This feature is currently available in the Huawei Watch GT 6 Pro, through an official update announced at the World Health Expo 2026 in Dubai.
The watch does not measure blood sugar levels directly, meaning it does not display traditional values such as “mmol/L” or “mg/dL”.
But it relies on photoplethysmography (“PPG”) technology and additional sensors to analyze a set of indicators over a period ranging from three to fourteen days, according to a report by the “TechRadar” website, which specializes in the field of technology.
After this period ends, the user can view the results through the “Diabetes Risk” application on the watch.
So far, the Watch GT 6 Pro is the only Huawei device that supports this feature, but the company intends to make it available in other products in the near future.
While Apple and Samsung continue their efforts to find ways to estimate the risk of diabetes without the need to take blood samples, smart watches are expected to witness major developments in this field soon.
However, there are some points to keep in mind about this feature. The first is that the “Watch GT 6 Pro” is not available in all countries of the world, including the United States.
In addition, no independent tests have been conducted yet to compare the watch’s accuracy with continuous blood glucose meters, so Huawei’s claims should be treated with caution.
Wearable devices continue to complement the careful medical examinations conducted by the doctor, but, if proven accurate, they may represent an important step for diabetics and those who want to assess their level of risk of developing the disease. (Arabic)
